Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Duffaud

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Current Treatment Options in Oncology|September 30, 2022
Regorafenib for the Treatment of SarcomaJean-Yves Blay, Florence Duffaud, Suzanne George, et al.
The Lancet. Oncology|October 5, 2023
Pembrolizumab monotherapy for advanced chordoma - Authors' replyJean-Yves Blay, Nicolas Penel, Florence Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcomaFlorence Duffaud, Gerlinde Egerer, Stefano Ferrari, et al.
Revue De L'Infirmiere|November 29, 2017
[Sophrology for developing strategies to help patients adapt to cancer treatments]Michelle Gaide, Frédérique Surdej, Christelle Daoud-Carrera, et al.
Neuro-Chirurgie|April 15, 2024
Primary intradural Extraosseous Ewing's sarcoma of the cauda equina: A case report and literature reviewManel Krouma, Kaissar Farah, Anis Choucha, et al.
Bulletin Du Cancer|November 21, 2002
[Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example]Laurence Digue, Thierry Orsière, Marjorie Baciuchka-Palmaro, et al.
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Impact of a brochure on pain destined for thoracic oncology patients]Fabrice Barlési, Florence Duffaud, Christophe Doddoli, et al.
Cancers|March 29, 2019
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with TrabectedinAlexandre de Nonneville, Dominique Barbolosi, Maeva Andriantsoa, et al.
Therapeutic Drug Monitoring|November 27, 2002
Population pharmacokinetics of etoposide: application to therapeutic drug monitoringJoseph Ciccolini, Suzanne Monjanel-Mouterde, Sok-Siya Bun, et al.
Acta Oncologica (Stockholm, Sweden)|March 5, 2019
Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trialsMelissa Vos, Stefan Sleijfer, Saskia Litière, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Current Treatment Options in Oncology|September 30, 2022
Regorafenib for the Treatment of SarcomaJean-Yves Blay, Florence Duffaud, Suzanne George, et al.
The Lancet. Oncology|October 5, 2023
Pembrolizumab monotherapy for advanced chordoma - Authors' replyJean-Yves Blay, Nicolas Penel, Florence Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcomaFlorence Duffaud, Gerlinde Egerer, Stefano Ferrari, et al.
Revue De L'Infirmiere|November 29, 2017
[Sophrology for developing strategies to help patients adapt to cancer treatments]Michelle Gaide, Frédérique Surdej, Christelle Daoud-Carrera, et al.
Neuro-Chirurgie|April 15, 2024
Primary intradural Extraosseous Ewing's sarcoma of the cauda equina: A case report and literature reviewManel Krouma, Kaissar Farah, Anis Choucha, et al.
Bulletin Du Cancer|November 21, 2002
[Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example]Laurence Digue, Thierry Orsière, Marjorie Baciuchka-Palmaro, et al.
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Impact of a brochure on pain destined for thoracic oncology patients]Fabrice Barlési, Florence Duffaud, Christophe Doddoli, et al.
Cancers|March 29, 2019
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with TrabectedinAlexandre de Nonneville, Dominique Barbolosi, Maeva Andriantsoa, et al.
Therapeutic Drug Monitoring|November 27, 2002
Population pharmacokinetics of etoposide: application to therapeutic drug monitoringJoseph Ciccolini, Suzanne Monjanel-Mouterde, Sok-Siya Bun, et al.
Acta Oncologica (Stockholm, Sweden)|March 5, 2019
Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trialsMelissa Vos, Stefan Sleijfer, Saskia Litière, et al.
Pageof 14